Terms: = Sarcomas AND AKT1, P31749, RAC-ALPHA, RAC, PRKBA, PKB-ALPHA, PKB, MGC99656, AKT, ENSG00000142208, 207
1550 results:
1. Role of Protein Tyrosine Phosphatase Receptor Type E (PTPRE) in Chemoresistant Retinoblastoma.
Mohren L; Doege A; Miroschnikov N; Dräger O; Busch MA; Dünker N
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38674157
[TBL] [Abstract] [Full Text] [Related]
2. Vitexicarpin Induces Apoptosis and Inhibits Metastatic Properties via the akt-PRAS40 Pathway in Human Osteosarcoma.
Yun HM; Kwon HS; Lee JY; Park KR
Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612399
[TBL] [Abstract] [Full Text] [Related]
3. Ferroptosis Altered microRNAs Expression in HT-1080 Fibrosarcoma Cells Based on Small RNA Sequencing and Bioinformatics Analysis.
Zhang Q; Wang Q; Ding H; Hu C; Feng J
Nutrients; 2024 Mar; 16(6):. PubMed ID: 38542784
[TBL] [Abstract] [Full Text] [Related]
4. USP3 promotes osteosarcoma progression via deubiquitinating EPHA2 and activating the PI3K/akt signaling pathway.
Li A; Wang S; Nie J; Xiao S; Xie X; Zhang Y; Tong W; Yao G; Liu N; Dan F; Shu Z; Liu J; Liu Z; Yang F
Cell Death Dis; 2024 Mar; 15(3):235. PubMed ID: 38531846
[TBL] [Abstract] [Full Text] [Related]
5. A recurrent NTRK1 tyrosine kinase domain mutation pair is characteristic in a subset of dedifferentiated liposarcomas.
Lippai Z; Péterfia B; Papp G; Dezső K; Bedics G; Pápai Z; Lamers MH; Kuin RC; Szuhai K; Sápi Z
Eur J Cancer; 2024 May; 202():114005. PubMed ID: 38531265
[TBL] [Abstract] [Full Text] [Related]
6. Screening for Synergistic Reagents With Pazopanib Against Osteosarcoma Using a Compound Library.
Yada Y; Asanuma K; Kakimto T; Okuno K; Okamoto T; Iino T; Nakamura T; Sudo A
Anticancer Res; 2024 Mar; 44(3):1071-1078. PubMed ID: 38423639
[TBL] [Abstract] [Full Text] [Related]
7. Mefenamic acid exhibits antitumor activity against osteosarcoma by impeding cell growth and prompting apoptosis in human osteosarcoma cells and xenograft mice model.
Ye J; Chang T; Zhang X; Wei D; Wang Y
Chem Biol Interact; 2024 Apr; 393():110931. PubMed ID: 38423378
[TBL] [Abstract] [Full Text] [Related]
8. Identifying squalene epoxidase as a metabolic vulnerability in high-risk osteosarcoma using an artificial intelligence-derived prognostic index.
Wang Y; Ma X; Xu E; Huang Z; Yang C; Zhu K; Dong Y; Zhang C
Clin Transl Med; 2024 Feb; 14(2):e1586. PubMed ID: 38372422
[TBL] [Abstract] [Full Text] [Related]
9. LncRNA RPARP-AS1 promotes the progression of osteosarcoma cells through regulating lipid metabolism.
Cai F; Liu L; Bo Y; Yan W; Tao X; Peng Y; Zhang Z; Liao Q; Yi Y
BMC Cancer; 2024 Feb; 24(1):166. PubMed ID: 38308235
[TBL] [Abstract] [Full Text] [Related]
10. Role of PAX6, TRPA1, BCL11B, MCOLN2, CUX1, EMX1 in colorectal cancer and osteosarcoma.
Zhang J; Gao Q; Hou S; Chi X; Zheng M; Zhang Q; Shan H; Zhang X; Kang C
Medicine (Baltimore); 2024 Feb; 103(5):e37056. PubMed ID: 38306561
[TBL] [Abstract] [Full Text] [Related]
11. The role of high mobility group AT-hook 1 in viral infections: Implications for cancer pathogenesis.
Akade E; Jalilian S
Int J Biochem Cell Biol; 2024 Apr; 169():106532. PubMed ID: 38278412
[TBL] [Abstract] [Full Text] [Related]
12. Immune characteristics of dedifferentiated retroperitoneal liposarcomas and the reliability of regional samples in evaluating their tumor immune microenvironments.
Zhou C; Li M; Ren Y; Miao F; Wang Y; Wu T; Gou X; Li W
World J Surg Oncol; 2024 Jan; 22(1):25. PubMed ID: 38254190
[TBL] [Abstract] [Full Text] [Related]
13. Effect of traditional Chinese medicine in osteosarcoma: Cross-interference of signaling pathways and potential therapeutic targets.
Liu Y; Jiang B; Li Y; Zhang X; Wang L; Yao Y; Zhu B; Shi H; Chai X; Hu X; Zhang B; Li H
Medicine (Baltimore); 2024 Jan; 103(3):e36467. PubMed ID: 38241548
[TBL] [Abstract] [Full Text] [Related]
14. Targeting POLRMT by a first-in-class inhibitor IMT1 inhibits osteosarcoma cell growth in vitro and in vivo.
Kong Y; Li X; Zhang H; Fu B; Jiang HY; Yang HL; Dai J
Cell Death Dis; 2024 Jan; 15(1):57. PubMed ID: 38228583
[TBL] [Abstract] [Full Text] [Related]
15. Mechanism of lysine oxidase-like 1 promoting synovial inflammation mediating rheumatoid arthritis development.
Hu J; Liu X; Xu Q; Zhu M; Wang S; Quan K; Dai M; Mo F; Zhan H
Aging (Albany NY); 2024 Jan; 16(1):928-947. PubMed ID: 38217541
[TBL] [Abstract] [Full Text] [Related]
16. A study protocol for an open-label, single-arm, single-center phase I clinical study on tolerability, safety, and efficacy of dalpiciclib combined with apatinib in the treatment of patients with advanced or metastatic sarcoma.
Huang H; Zhang H; Cao B
Thorac Cancer; 2024 Feb; 15(5):427-433. PubMed ID: 38211967
[TBL] [Abstract] [Full Text] [Related]
17. Predicting prognosis and immune status in sarcomas by identifying necroptosis-related lncRNAs.
Wang Z; He A; Lu Z; Xu W; Wu G; Peng T
Aging (Albany NY); 2024 Jan; 16(1):493-517. PubMed ID: 38194709
[TBL] [Abstract] [Full Text] [Related]
18. Soy isoflavones induces mitophagy to inhibit the progression of osteosarcoma by blocking the akt/mTOR signaling pathway.
Zheng Z; Zhao X; Yuan B; Jiang S; Yan R; Dong X; Yao Q; Liang H
Mol Med; 2024 Jan; 30(1):5. PubMed ID: 38191316
[TBL] [Abstract] [Full Text] [Related]
19. Exploration of anti‑osteosarcoma activity of asiatic acid based on network pharmacology and
Pang H; Wu H; Zhan Z; Wu T; Xiang M; Wang Z; Song L; Wei B
Oncol Rep; 2024 Feb; 51(2):. PubMed ID: 38186298
[TBL] [Abstract] [Full Text] [Related]
20. Lenvatinib Suppresses Protein Kinase B Signaling and Induces Apoptosis in Osteosarcoma Cells.
Li CY; Chen HC; Liao CY; Hsu FT; Hung KC; Liu KC; Chen JC; Ku MC
Anticancer Res; 2024 Jan; 44(1):85-92. PubMed ID: 38160012
[TBL] [Abstract] [Full Text] [Related]
[Next]
